A new study suggests that appendectomy can reduce risk
Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity. Researchers have found that their appendix tissue has protein clusters similar to those observed in the brains of Parkinson's disease patients. This discovery suggests that the appendix plays a role in the early stages of this disease by aggregating these same proteins. These proteins contribute to Parkinson's disease in some way, so appendectomy may prevent their harmful activity.
Recommended Posts
-
Biyun Tian was founded in 2001 by international students working and studying at Harvard University. For over 20 years, we have been dedicated to independent research and development as well as production. Established in 2007, Shanghai Biyuntian Biotechnology Co., Ltd. is a national level specialized, refined, unique, and new "Little Giant" enterprise. It was further selected as one of the second batch of national level specialized, refined, unique, and new "Little Giant" enterprises recommended for support in the first year. It is also a Shanghai Science and Technology Little Giant Enterprise, a leading enterprise in the G60 Science and Technology Innovation Corridor, one of the top 100 private enterprises driving science and technology innovation in the Yangtze River Delta G60 Science and Technology Innovation Corridor, a "TOP100" brand value list... -
Suzhou Yikesai Biotechnology Co., Ltd., with the mission of "accelerating the application of life sciences and benefiting people's health", is committed to solving the bottleneck of biopharmaceuticals and achieving the localization of key raw materials. It has become one of the excellent enterprises in the upstream core raw materials of biopharmaceuticals in China. The company is a national high-tech enterprise, a national specialized and innovative small giant enterprise, a member of the China International Serum Industry Association (ISIA), and a research center for CD serum-free culture medium engineering in the fields of biopharmaceuticals and cell therapy in Jiangsu Province.The company currently focuses on three major product segments: serum-free culture media, fetal bovine serum, and identification reagents, providing international quality products and servic...
-
Zhongshan Kangtian Shenghe Biotechnology Co., Ltd. (referred to as "Kangsheng Biotechnology")Overseas ReturneesFounded in April 2018 by Dr. Pan Honghui and several other experts, [2] settled inZhongshan National Health Science and Technology Industry Base——Zhongde (Zhongshan) Biomedical Industry Park is a company that integrates research and development, production, and servicesinternationalizationBiotechnologyThe company. [4] Its core product is applied to proteinsMonoclonal antibodyMedicationsvaccinesDrug development and productionSerum-free culture medium, including chemically restricted culture media, non animal derived culture media [1], and commercially authorizedCHO cellsZhu Development Platform [5]....
